Interleukin‐4 Boosts Insulin‐Induced Energy Deposits by Enhancing Glucose Uptake and Lipogenesis in Hepatocytes
Open Access
- 1 January 2018
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 6923187
Abstract
Type 2 diabetes mellitus (T2DM), with dysregulated hepatic gluconeogenesis as the major cause of fasting hyperglycemia, is closely associated with chronic inflammation. We previously demonstrated interleukin‐4 (IL‐4) improves insulin sensitivity and glucose tolerance while reducing lipid deposits. The present study examined the in vitro effects of IL‐4 on insulin signaling molecules, glucose uptake, and lipid metabolism in hepatocytes, as well as in vivo effects on hepatic adiposity, for elucidating the roles of IL‐4 in hepatic energy metabolism. Potential interaction between IL‐4 and insulin in regulating hepatic metabolism was also investigated. Our results showed that IL‐4 enhanced Akt and GSK‐3α/β phosphorylations, which in turn promoted glycogen synthesis. IL‐4 not only potentiated basal glucose uptake by upregulating glucose transporter 2 expression but also promoted insulin‐induced glucose uptake. Additionally, IL‐4 increased triglyceride contents through facilitating free fatty acid uptake and expression/activity of lipogenic enzymes. The major effects of IL‐4 on the liver were to promote energy storage by boosting insulin‐stimulated glucose uptake and lipid synthesis. This study provides evidence to implicate the novel roles of IL‐4 in mediating hepatic glucose and lipid metabolism, interactions between immune responses and metabolic homeostasis, and the involvement of IL‐4 in metabolic abnormalities.Keywords
Funding Information
- Ministry of Education (106AC-P686)
- University System of Taiwan (VGHUST105-G7-8-1, VGHUST104-G7-8-1)
- Ministry of Science and Technology, Taiwan (106-2314-B-010-032, 105-2320-B-241-005)
This publication has 65 references indexed in Scilit:
- A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolismNature Medicine, 2011
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist #Hepatology, 2009
- Cytokine-stimulated phosphorylation of GSK-3 is primarily dependent upon PKCs, not PKBBiochemistry and Cell Biology, 2006
- Disease model: hyperinsulinemia and insulin resistanceTrends in Molecular Medicine, 2001
- Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytesHepatology, 1998
- Interleukin-6 Enhances Glucose Transport in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1996
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.Journal of Clinical Investigation, 1995
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- A Reinvestigation of the Phosphorylation of Rabbit Skeletal‐Muscle Glycogen Synthase by Cyclic‐AMP‐Dependent Protein KinaseEuropean Journal of Biochemistry, 1981